Co-Analgesics (Adjuvant Medications)
This group includes agents that affect neuronal neurotransmitter reuptake, ion channels, and various CNS receptors. They are not classified as opioids (with the exception of fentanyl and buprenorphine, which are true opioids and are not considered adjuvants).
Tricyclic Antidepressants This subclass includes amitriptyline and imipramine (Imizin). Their analgesic mechanism involves the inhibition of neuronal reuptake of monoamines—norepinephrine and serotonin. The accumulation of these neurotransmitters in synapses leads to the activation of the descending antinociceptive system. As a result, pain impulse transmission is inhibited directly at the spinal cord level. These drugs are indicated for chronic pain, phantom limb pain, and neuralgias of various etiologies.
Anticonvulsants This category includes sodium channel blockers such as carbamazepine (Tegretol) and phenytoin (Diphenin). Their mechanism is based on blocking membrane sodium channels, which reduces pathological neuronal hyperexcitability. They possess high specific efficacy in trigeminal neuralgia, which is typically characterized by paroxysms of severe pain.
GABAergic System Modulators
- Gabapentin: An anticonvulsant agent whose mechanism involves enhancing GABAergic transmission in the CNS. It is successfully used for migraines and severe neuropathic pain.
- Baclofen: Acts as a GABA$_B$ receptor agonist. It is widely used to relieve painful muscle spasms and eliminate spasticity.
General Anesthetics and Other Agents
Certain general anesthetic agents possess powerful concomitant analgesic effects.
- Ketamine: A phencyclidine derivative acting as a non-competitive NMDA receptor antagonist. The drug induces a state known as dissociative anesthesia and provides potent analgesia. Its primary application is general anesthesia.
- Nitrous oxide: Administered via inhalation. It is indicated for relieving severe pain during myocardial infarction, obstetric analgesia during labor, and in the early postoperative period.
Additionally, other drug classes exhibit some degree of analgesic activity, albeit less pronounced, such as $H_1$ receptor antagonists (diphenhydramine), somatostatin, and calcitonin.
Analgesics with a Mixed Mechanism of Action
A prominent representative of this group is tramadol (Tramal), which combines both opioid and non-opioid components of analgesia.
Pharmacodynamics of Tramadol (Dual Mechanism):
- Opioid component: The drug acts as a central non-selective agonist at $\mu$-, $\delta$-, and $\kappa$-opioid receptors.
- Non-opioid (monoaminergic) component: Similar to antidepressants, tramadol inhibits the neuronal reuptake of norepinephrine and serotonin, thereby enhancing descending inhibitory pathways on pain transmission in the spinal cord.
Safety Profile and Advantages: Although tramadol is less potent as an analgesic compared to classical morphine, it has a significantly superior safety profile. The drug causes virtually no respiratory depression, does not suppress gastrointestinal motility (minimizing the risk of severe constipation), and does not increase urinary tract tone. Furthermore, it has a significantly lower abuse potential (the risk of drug dependence is substantially lower than that of classical opioids) and is not scheduled as a strict narcotic.
Indications:
- Postoperative pain
- Pain syndromes in myocardial infarction
- Cancer pain
- Severe trauma
It is versatile in its routes of administration: parenteral, oral, and rectal.